Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$571,581,749
+$114,554,450 QoQ
Shares Held
4,448,107
+17.1% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#59
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caisse de depot et placement du Quebec holds $3,472,564,051 across 11 Drug Manufacturers - General names. MRK ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
805,809 | $966,511,569 | |
| 2 | JNJ |
Johnson & Johnson
|
2,259,196 | $573,768,008 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
4,448,107 | $571,581,749 | |
| 4 | ABBV |
AbbVie Inc.
|
1,641,631 | $413,100,024 | |
| 5 | AZN |
Astrazeneca PLC
|
1,463,843 | $277,573,909 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,083,390 | $263,215,492 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,228,503 | $243,646,342 | |
| 8 | BIIB |
Biogen Inc.
|
510,194 | $110,232,515 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $571,581,749 | 4,448,107 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $457,027,299 | 3,799,379 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $434,877,269 | 4,131,458 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $400,100,185 | 4,767,070 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $349,895,986 | 4,420,111 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $387,351,201 | 4,315,410 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $414,452,780 | 4,166,192 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $611,923,851 | 5,388,551 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $395,428,094 | 3,194,088 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $500,570,534 | 3,793,638 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $557,693,227 | 5,115,513 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $561,378,628 | 5,452,925 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $670,948,540 | 5,814,616 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $610,048,983 | 5,734,082 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $577,545,565 | 5,205,458 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $586,233,308 | 6,807,168 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $540,512,741 | 5,928,625 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $400,582,294 | 4,882,173 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $105,017,722 | 1,370,273 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $114,490,173 | 1,524,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $81,981,323 | 1,054,151 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $28,142,567 | 365,061 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $22,994,542 | 281,107 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $29,406,866 | 354,513 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,988,192 | 103,300 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $42,047,692 | 546,500 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||